Jane Street’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
Jane Street's MLYS Position: Q3 2026 in Review
Jane Street opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 215,209 shares worth $5.41M. The stake represents ﹤0.01% of the portfolio and ranks #3620 among its holdings. This is a return to the name: Jane Street previously reported a position in MLYS as recently as Q3 2025.
Jane Street first reported a position in MLYS in Q3 2023 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- Jane Street held 215,209 shares of Mineralys Therapeutics worth $5.41M as of Q3 2026.
- Mineralys Therapeutics was a new Jane Street position in Q3 2026.
- Mineralys Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3620 holding.
- Jane Street first reported a position in Mineralys Therapeutics in Q3 2023 and has held it in 6 quarters since.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.